The changes of leukocytes and T lymphocytes in atopic dermatitis patients with and without dupilumab therapy and in control group in pollen season compared to out of pollen season

J Dermatolog Treat. 2024 Dec;35(1):2318351. doi: 10.1080/09546634.2024.2318351. Epub 2024 Feb 25.

Authors

Jarmila Čelakovská¹, Eva Čermáková², Petra Boudkova³, Jan Krejsek³

Affiliations

¹ Department of Dermatology and Venereology Faculty Hospital and Medical Faculty of Charles University, Hradec Králové, Czech Republic.
² Department of Medical Biophysics, Medical Faculty of Charles University, Hradec Králové, Czech Republic.
³ Department of Clinical Immunology and Allergy, Faculty Hospital and Medical Faculty of Charles University, Hradec Králové, Czech Republic.

PMID: 38403278
DOI: 10.1080/09546634.2024.2318351

No abstract available

MeSH terms

Antibodies, Monoclonal, Humanized*
Control Groups
Dermatitis, Atopic* / drug therapy
Humans
Leukocytes
Pollen
Seasons
T-Lymphocytes

Substances

dupilumab
Antibodies, Monoclonal, Humanized